Navigation Links
Microarray Markets - 2013 Report Examines Companies that are Actively Developing and Marketing Microarray Instrumentation or Microarray Biochips
Date:11/20/2013

DUBLIN, November 20, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/84xb3g/microarray_markets) has announced the addition of the "Microarray Markets" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Microarray technologies multiplex and miniaturize the analysis of tens of thousands of molecules for a variety of assays, including drug binding, molecular interactions, enzyme activity and pathway identification. These microarrays, which include DNA microarrays, protein microarrays, tissue microarrays, low complexity microarrays and carbohydrate microarrays, are excellent tools for gene expression profiling, biomarker profiling and diagnostics.

Pharmaceutical and biotechnology researchers use microarrays to streamline drug target identification, selection, validation and predictive testing. Rapid growth in the clinical research and diagnostic devices markets holds great potential for applications of microarray technology, including basic research, clinical trials and diagnostic devices.

This report describes the specific segment of the microarray market aimed at the analysis of proteins and DNA. It examines various microarray platforms and the technologies that are utilized in hospitals, clinics, commercial laboratories and research institutions to detect DNA and proteins for the purpose of drug discovery, disease diagnosis and disease monitoring.  Detailed tables and charts with sales forecasts and marketshare data are also included.


Companies Mentioned:

- Affymetrix
- Agilent Technologies, Inc
- AyoxxA
- Bio-Rad Laboratories
- BioCat GmbH
- CYBRDI
- Cancer Genetics, Inc
- Cepheid, Inc
- DiagnoSwiss SA
- Exiqon
- Fluidigm Corporation
- GE Healthcare
- Gyros AB
- Healthcare IT, Inc
- Illumina, Inc
- InDevR
- Luminex Corporation
- Myriad Genetics, Inc
- NextGen Sciences PLC
- One Lambda
- ProteoGenix
- QIAGEN
- R&D Systems
- RayBiotech
- Toray Industries, Inc
- Trans Genic, Inc
- US Biomax
- Veredus Laboratories Pte Ltd
- Zeus Scientific, Inc
- Zyagen


For more information visit http://www.researchandmarkets.com/research/84xb3g/microarray_markets

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Ingenuity Systems and Affymetrix Partner to Eliminate Microarray Expression Analysis Bottleneck
2. Global Biochips and Microarrays 2013 Market Report
3. Phalanx Biotech Group Announces CytoOneArray®, a Targeted Chromosomal Microarray
4. Stem Cell Markets - 2013 Report Examines the Use of Stem Cells in Developing New Therapies for Disease
5. BCC Research Publishes a New Report On Global Markets for Flow Cytometry
6. Globalizing Clinical Trials to Include Emerging Markets, New Life Science Webinar Hosted by Xtalks
7. BCC Research Publishes a New Report on Global Markets for Biochips
8. BCC Research Publishes a New Report On Global Markets for Rnai Technologies
9. Interventional Cardiology Devices - Emerging Markets 2009-2015
10. IDC MarketScape annovera la soluzione cloud-based di Veeva tra le principali soluzioni CRM dedicate alle scienze della vita
11. IDC MarketScape Named Cloud-based Veeva a Leader in Life Sciences CRM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017 Kineta, Inc., a biotechnology ... therapies in immuno-oncology, today announced the discovery and ... compounds that activate interferon response factor 3 (IRF3) ... immune-mediated tumor regression in a murine colon carcinoma ... demonstrated complete tumor regression to initial drug treatment ...
(Date:3/23/2017)... Orleans, La. (PRWEB) , ... March 23, 2017 ... ... real-time, industrial monitoring solutions, today announced the hire of Dr. Sigmund “Sig” Floyd ... APMT customer applications, strategic partnerships and joint development activities. , “Dr. Floyd’s career ...
(Date:3/22/2017)... , March 22, 2017 Good Start Genetics, ... has eclipsed the 130 million covered lives mark through ... of Texas . With newly signed ... continues to enjoy strong payor acceptance based on the ... programs and genetic counseling, its industry-leading customer care and ...
(Date:3/22/2017)... - FACIT announced a seed stage investment in ... created by FACIT focused on developing a portfolio ... non-dilutive capital, achieves a targeted $3.0M financing for ... to accelerate the nomination of a candidate drug ... a strategic partnership for clinical trials in patients ...
Breaking Biology Technology:
(Date:2/21/2017)... and PORTLAND, Ore. , Feb. 22, ... Avamere Family of Companies (Avamere Health Services, Infinity Rehab, ... six-month research study that will apply the power of ... senior living and health centers. By analyzing data streaming ... gain insights into physical and environmental conditions, and obtain ...
(Date:2/16/2017)... 16, 2017  Genos, a community for personal ... has received Laboratory Accreditation from the College of ... to laboratories that meet stringent requirements around quality, ... processes. "Genos is committed to maintaining ... We,re honored to be receiving CAP accreditation," said ...
(Date:2/13/2017)... 2017  RSA Conference -- RSA, a Dell Technologies ... to enhance fraud detection and investigation across digital ... Fraud & Risk Intelligence Suite. The new platform ... insights from internal and external sources as well ... customers from targeted cybercrime attacks. "Fraudsters ...
Breaking Biology News(10 mins):